Revisor Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$763K Buy
5,906
+2,587
+78% +$303K 0.18% 137
2026
Q1
$401K Buy
3,319
+58
+2% +$6.7K 0.11% 204
2025
Q4
$355K Buy
3,261
+87
+3% +$8.17K 0.1% 215
2025
Q3
$278K Buy
3,174
+139
+5% +$11.4K 0.1% 219
2025
Q2
$255K Sell
3,035
-588
-16% -$46.7K 0.09% 238
2025
Q1
$327K Buy
+3,623
New +$338K 0.15% 160
2024
Q4
Sell
-2,199
Closed -$250K 157
2024
Q3
$250K Buy
2,199
+403
+22% +$47.9K 0.16% 148
2024
Q2
$222K Sell
1,796
-1,535
-46% -$198K 0.15% 145
2024
Q1
$400K Buy
+3,331
New +$411K 0.18% 135
2023
Q4
Sell
-2,227
Closed -$229K 157
2023
Q3
$229K Buy
2,227
+460
+26% +$49.6K 0.19% 136
2023
Q2
$204K Buy
+1,767
New +$201K 0.18% 154

Other funds holding MRK

Revisor Wealth Management's MRK Position: Q2 2026 in Review

Revisor Wealth Management increased its Merck (MRK) stake by 78% in Q2 2026, buying an estimated $303K and bringing the position to 5,906 shares worth $763K. The position accounts for 0.18% of the portfolio, ranked #137.

Revisor Wealth Management first reported a position in MRK in Q2 2023 and has held it in 11 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Revisor Wealth Management held 5,906 shares of Merck worth $763K as of Q2 2026.
  • Revisor Wealth Management bought 2,587 Merck shares in Q2 2026, an estimated $303K.
  • Merck made up 0.18% of Revisor Wealth Management's portfolio in Q2 2026, its #137 holding.
  • Revisor Wealth Management first reported a position in Merck in Q2 2023 and has held it in 11 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.